Vicapsys Life Sciences Vicapsys Life Sciences

Press releases and disclosure

Vicapsys Life Sciences completes reverse merger with Stateline Distributors of Puerto Rico and signs definitive agreement to acquire NitroMist®

Vicapsys Life Sciences, Inc. (OTC: VICP)Issued through ACCESS Newswire

Summary. The full text of the release as issued is on ACCESS Newswire and on the OTC Markets Disclosure & News Service.

The merger closed effective September 3, 2026, and Stateline is now a wholly owned subsidiary. Under the merger agreement executed August 12, 2026, Stateline's shareholders received newly designated Series C Convertible Preferred Stock.

The company also signed a definitive agreement to acquire NitroMist®, the FDA-approved nitroglycerin lingual aerosol, with closing to follow FDA acknowledgment of the NDA transfer.

Full release on ACCESS Newswire OTC Markets news for VICP

Investor and media inquiries: investors@vicapsys.com, (305) 565-8002.